First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 167.29 USD -0.3% Market Closed
Updated: Apr 26, 2024

Abbvie Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Selling, General & Administrative Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$12.7B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-14%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.2B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.6B
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
-23%
Seagen Inc
NASDAQ:SGEN
Selling, General & Administrative
-$922.1m
CAGR 3-Years
-23%
CAGR 5-Years
-33%
CAGR 10-Years
-26%

See Also

What is Abbvie Inc's Selling, General & Administrative?
Selling, General & Administrative
-12.7B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Selling, General & Administrative amounts to -12.7B USD.

What is Abbvie Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-9%

Over the last year, the Selling, General & Administrative growth was 15%. The average annual Selling, General & Administrative growth rates for Abbvie Inc have been -4% over the past three years , -11% over the past five years , and -9% over the past ten years .